Previous research has revealed that CDK1 is present in the cell cycle of numerous tumor-regulating cell adhesions [23] and may served as a potential biomarker for non-small-cell lung cancer(NSCLC) [24], CRC [25], breast cancer [26], and ovarian cancer [27]. This evidence concerns the gene CDK1 and non-small cell lung carcinoma.